tiprankstipranks
Dechra Pharmaceuticals PLC (GB:DPH)
LSE:DPH
UK Market

Dechra Pharmaceuticals (DPH) Share Forecast & Price Target

7 Followers
See the Price Targets and Ratings of:

DPH Analyst Ratings

Currently, no data available
Based on 0 analysts giving stock ratings to
Dechra
Pharmaceuticals
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

DPH Stock 12 Month Forecast

There Are No Analyst Ratings for GB:DPH In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

DPH Financial Forecast

No data currently available

DPH Earnings Forecast

Currently, no earnings data available.
Currently, no earnings data available.
No data currently available

DPH Sales Forecast

Currently, no sales data available.
Currently, no sales data available.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Stifel Nicolaus
3875.00p
Hold
0.23%
Upside
Downgraded
06/27/23
Stifel Downgrades Dechra Pharma (DPH:LN) (DCHPF) to HoldStifel analyst Max Herrmann downgraded Dechra Pharma (DPH:LN) (OTC: DCHPF) from Buy to Hold with a price target of GBP38.75 (from GBP40.00).
Exane BNP Paribas
4070.00p
Buy
5.28%
Upside
Upgraded
05/25/23
Exane BNP Paribas Upgrades Dechra Pharma (DPH:LN) (DCHPF) to OutperformExane BNP Paribas analyst Laurent Gelebart upgraded Dechra Pharma (DPH:LN) (OTC: DCHPF) from Neutral to Outperform with a price target of GBP40.70.
J.P. Morgan
4000.00p
Buy
3.47%
Upside
Reiterated
03/07/23
Dechra Pharma (DPH:LN) (DCHPF) PT Lowered to GBP40 at JPMorganJPMorgan analyst James Gordon lowered the price target on Dechra Pharma (DPH:LN) (OTC: DCHPF) to GBP40.00 (from GBP46.00) while maintaining a Overweight rating.
HSBC
4960.00p
Buy
28.30%
Upside
Reiterated
03/06/23
Jefferies
3112.00p
Buy
-19.50%
Downside
Reiterated
02/28/23
Dechra Pharma (DPH:LN) (DCHPF) PT Raised to GBP31.24 at JefferiesJefferies analyst James Vane-Tempest raised the price target on Dechra Pharma (DPH:LN) (OTC: DCHPF) to GBP31.24 (from GBP31.12) while maintaining a Buy rating.
Berenberg Bank
2850.00p
Hold
-26.28%
Downside
Reiterated
02/27/23
Numis Analyst forecast on GB:DPH
Unknown Analyst
Not Ranked
Numis
4000.00p
Buy
3.47%
Upside
Reiterated
05/22/23
Deutsche Bank Analyst forecast on GB:DPH
Unknown Analyst
Not Ranked
Deutsche Bank
4070.00p
Buy
5.28%
Upside
Reiterated
05/25/23

Best Analysts Covering Dechra Pharmaceuticals

Which Analyst Should I Follow If I Want to Buy GB:DPH and Sell After:
1 Month
James VaneJefferies
Success Rate
4/5 ratings generated profit
80%
Average Return
+3.88%
reiterated a buy rating a year ago
Copying James Vane's trades and holding each position for 1 Month would result in 80.00% of your transactions generating a profit, with an average return of +3.88% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
3 Months
James VaneJefferies
Success Rate
5/5 ratings generated profit
100%
Average Return
+13.96%
reiterated a buy rating a year ago
Copying James Vane's trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +13.96% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
1 Year
Success Rate
7/9 ratings generated profit
78%
Average Return
+7.91%
reiterated a buy rating a year ago
Copying Anand Date's trades and holding each position for 1 Year would result in 77.78% of your transactions generating a profit, with an average return of +7.91% per trade.
2 Years
James VaneJefferies
Success Rate
5/5 ratings generated profit
100%
Average Return
+28.02%
reiterated a buy rating a year ago
Copying James Vane's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +28.02% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

DPH Analyst Recommendation Trends

Rating
Jan 23
Feb 23
Mar 23
May 23
Jun 23
Strong Buy
3
2
2
0
0
Buy
2
2
4
7
5
Hold
2
3
1
1
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
7
7
7
8
6
In the current month, DPH has received 5 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. DPH average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

DPH Stock Forecast FAQ

What is GB:DPH’s average 12-month price target, according to analysts?
Currently, no data Available
What is GB:DPH’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for GB:DPH, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Dechra Pharmaceuticals PLC a Buy, Sell or Hold?
      Currently, no data Available
      What is Dechra Pharmaceuticals PLC’s share price target?
      Currently, no data Available
      What do analysts say about Dechra Pharmaceuticals PLC?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Dechra Pharmaceuticals PLC?
      To buy shares of GB:DPH, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis